Cargando…

Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation

OBJECTIVES: Our objective was to examine gender differences in clinical presentation, management and prognosis of atrial fibrillation (AF) in a contemporary cohort. METHODS: In 6412 patients, 39.7% women, of the PREvention oF thromboembolic events – European Registry in Atrial Fibrillation, we exami...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schnabel, Renate B, Pecen, Ladislav, Ojeda, Francisco M, Lucerna, Markus, Rzayeva, Nargiz, Blankenberg, Stefan, Darius, Harald, Kotecha, Dipak, Caterina, Raffaele De, Kirchhof, Paulus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Cardiac Risk Factors and Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529986/ https://www.ncbi.nlm.nih.gov/pubmed/28228467 http://dx.doi.org/10.1136/heartjnl-2016-310406

Ejemplares similares

Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe
por: Schnabel, Renate B., et al.
Publicado: (2018)

Refined atrial fibrillation screening and cost-effectiveness in the German population
por: Schnabel, Renate B, et al.
Publicado: (2022)

Left ventricular longitudinal shortening: relation to stroke volume and ejection fraction in ageing, blood pressure, body size and gender in the HUNT3 study
por: Støylen, Asbjørn, et al.
Publicado: (2020)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Diagnostic accuracies of screening for atrial fibrillation by cardiac nurses versus radiographers
por: Kvist, Lærke Marius, et al.
Publicado: (2019)

Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation
por: Orlowski, Andi, et al.
Publicado: (2021)

New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs
por: Rutherford, Ole-Christian Walter, et al.
Publicado: (2018)

Is the association of QTc with atrial fibrillation and stroke in cohort studies a matter of time?
por: Radnahad, Navid, et al.
Publicado: (2022)

Cardiac rehabilitation for heart failure and atrial fibrillation: a propensity- matched study
por: Alhotye, Munyra, et al.
Publicado: (2023)

CHARGE-AF in a national routine primary care electronic health records database in the Netherlands: validation for 5-year risk of atrial fibrillation and implications for patient selection in atrial fibrillation screening
por: Himmelreich, Jelle C L, et al.
Publicado: (2021)

Weight change and the risk of incident atrial fibrillation: a systematic review and meta-analysis
por: Jones, Nicholas R, et al.
Publicado: (2019)

Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort
por: Handy, Alex, et al.
Publicado: (2022)

Cardiovascular risk after hospitalisation for unexplained syncope and orthostatic hypotension
por: Yasa, Ekrem, et al.
Publicado: (2018)

Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF
por: Camm, Christian Fielder, et al.
Publicado: (2022)

Risk factors and a 3-month risk score for predicting pacemaker implantation in patients with atrial fibrillation
por: Dalgaard, Frederik, et al.
Publicado: (2020)

CHA(2)DS(2)-VASc score stratifies mortality risk in patients with and without atrial fibrillation
por: Harb, Serge C, et al.
Publicado: (2021)

Associations between physical activity, left atrial size and incident atrial fibrillation: the Tromsø Study 1994–2016
por: Heitmann, Kim Arne, et al.
Publicado: (2022)

Incident cardiovascular, renal, metabolic diseases and death in individuals identified for risk-guided atrial fibrillation screening: a nationwide cohort study
por: Wu, Jianhua, et al.
Publicado: (2023)

Risk of atrial fibrillation and stroke among older men exposed to prolonged endurance sport practice: a 10-year follow-up. The Birkebeiner Ageing Study and the Tromsø Study
por: Johansen, Kristoffer Robin, et al.
Publicado: (2022)

Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of contemporary Japanese administrative claims data
por: Kohsaka, Shun, et al.
Publicado: (2020)

Systematic screening for cardiovascular risk at pharmacies
por: Rohla, Miklos, et al.
Publicado: (2016)

Nurse-coordinated care improves the achievement of LDL cholesterol targets through more intensive medication titration
por: Snaterse, Marjolein, et al.
Publicado: (2017)

Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk
por: Jørstad, Harald T, et al.
Publicado: (2016)

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
por: Rohla, Miklos, et al.
Publicado: (2019)

Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery
por: Bouri, Sonia, et al.
Publicado: (2014)

High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis
por: Tomaszewski, Maciej, et al.
Publicado: (2014)

Prescription of secondary prevention medications, lifestyle advice, and referral to rehabilitation among acute coronary syndrome inpatients: results from a large prospective audit in Australia and New Zealand
por: Redfern, Julie, et al.
Publicado: (2014)

Short-term effects of air pollution on a range of cardiovascular events in England and Wales: case-crossover analysis of the MINAP database, hospital admissions and mortality
por: Milojevic, Ai, et al.
Publicado: (2014)

On site assessment of cardiac function and neural regulation in amateur half marathon runners
por: Dalla Vecchia, Laura, et al.
Publicado: (2014)

B-type natriuretic peptide-guided therapy for perioperative medicine?
por: Shang, Charles
Publicado: (2014)

Subclinical atherosclerosis and silent myocardial ischaemia in patients with type 2 diabetes: a protocol of a clinico-observational study
por: Prasad, D S, et al.
Publicado: (2014)

Stress resilience and physical fitness in adolescence and risk of coronary heart disease in middle age
por: Bergh, Cecilia, et al.
Publicado: (2015)

Cardiovascular risk profile and frailty in a population-based study of older British men
por: Ramsay, S E, et al.
Publicado: (2015)

Angiotensin receptor blockers for prevention of cardiovascular disease: where does the evidence stand?
por: Fuchs, Flávio Danni, et al.
Publicado: (2015)

Prerace aspirin to protect susceptible runners from cardiac arrest during marathons: is opportunity knocking?
por: Siegel, Arthur J
Publicado: (2015)

Alcohol consumption and risk of incident heart failure in older men: a prospective cohort study
por: Wannamethee, S Goya, et al.
Publicado: (2015)

Lean body mass index prognostic value for cardiovascular events in patients with coronary artery disease
por: Hioki, Hirofumi, et al.
Publicado: (2015)

Association of ambulatory heart rate and atherosclerosis risk factors with blood pressure in young non-hypertensive adults
por: Cheng, Cynthia, et al.
Publicado: (2016)

Cardiac function associated with previous, current and repeated depression and anxiety symptoms in a healthy population: the HUNT study
por: Gustad, L T, et al.
Publicado: (2016)

Does the timing of cardiac rehabilitation impact fitness outcomes? An observational analysis
por: Fell, Jennifer, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kfncmmij80o5ta2kpsprthn7e7